In conclusion, this observational study of individuals with diabetes mellitus revealed two key findings: (1) eGFRdiff was associated with GDF‐15 independent of eGFRcr and (2) both eGFRdiff and GDF‐15 were associated with the risk of CKD progression, mortality and their composite outcome. Here, GDF15 is linked to chronic kidney disease.